Verition Fund Management LLC Sells 11,540 Shares of Axcelis Technologies, Inc. (NASDAQ:ACLS)

Verition Fund Management LLC decreased its position in shares of Axcelis Technologies, Inc. (NASDAQ:ACLS - Free Report) by 49.0% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 12,007 shares of the semiconductor company's stock after selling 11,540 shares during the period. Verition Fund Management LLC's holdings in Axcelis Technologies were worth $1,259,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also made changes to their positions in the business. CWM LLC lifted its position in shares of Axcelis Technologies by 4.8% in the 2nd quarter. CWM LLC now owns 1,506 shares of the semiconductor company's stock valued at $214,000 after acquiring an additional 69 shares in the last quarter. Xponance Inc. grew its stake in Axcelis Technologies by 4.7% during the 2nd quarter. Xponance Inc. now owns 2,061 shares of the semiconductor company's stock valued at $293,000 after acquiring an additional 92 shares in the last quarter. Andina Capital Management LLC increased its holdings in shares of Axcelis Technologies by 3.7% in the 2nd quarter. Andina Capital Management LLC now owns 2,791 shares of the semiconductor company's stock valued at $397,000 after purchasing an additional 99 shares during the period. Evergreen Capital Management LLC lifted its position in shares of Axcelis Technologies by 6.1% in the second quarter. Evergreen Capital Management LLC now owns 1,984 shares of the semiconductor company's stock worth $282,000 after purchasing an additional 114 shares in the last quarter. Finally, Nisa Investment Advisors LLC increased its position in Axcelis Technologies by 11.9% in the 3rd quarter. Nisa Investment Advisors LLC now owns 1,069 shares of the semiconductor company's stock worth $112,000 after purchasing an additional 114 shares during the last quarter. 89.98% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of equities research analysts have issued reports on the company. Needham & Company LLC reaffirmed a "hold" rating on shares of Axcelis Technologies in a research report on Friday, November 8th. Benchmark downgraded shares of Axcelis Technologies from a "buy" rating to a "hold" rating in a report on Friday, November 8th. Three investment analysts have rated the stock with a hold rating and four have given a buy rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and a consensus price target of $167.33.

Axcelis Technologies Price Performance

ACLS traded up $0.68 during midday trading on Friday, reaching $74.19. 444,207 shares of the company's stock were exchanged, compared to its average volume of 707,009. Axcelis Technologies, Inc. has a one year low of $69.35 and a one year high of $158.61. The firm has a market capitalization of $2.41 billion, a price-to-earnings ratio of 10.97, a price-to-earnings-growth ratio of 2.37 and a beta of 1.53. The business has a 50-day simple moving average of $86.54 and a two-hundred day simple moving average of $108.52. The company has a quick ratio of 3.29, a current ratio of 4.45 and a debt-to-equity ratio of 0.04.

About Axcelis Technologies

Axcelis Technologies, Inc designs, manufactures, and services ion implantation and other processing equipment used in the fabrication of semiconductor chips in the United States, Europe, and Asia Pacific. The company offers high energy, high current, and medium current implanters for various application requirements.